Novartis Announces Collaboration and Licensing Agreement with Surface Oncology
January 11, 2016 at 04:19 AM EST
Novartis (NYSE: NVS) continues to grow immuno-oncology pipeline through collaboration and licensing agreement with Surface Oncology ...